The Mpumalanga Men's Study (MPMS): results of a baseline biological and behavioral HIV surveillance survey in two MSM communities in South Africa.

The Mpumalanga Men's Study (MPMS) is the assessment of the Project Boithato HIV prevention intervention for South African MSM. Boithato aims to increase consistent condom use, regular testing for HIV-negative MSM, and linkage to care for HIV-positive MSM. The MPMS baseline examined HIV prevalen...

Full description

Bibliographic Details
Main Authors: Tim Lane, Thomas Osmand, Alexander Marr, Starley B Shade, Kristin Dunkle, Theodorus Sandfort, Helen Struthers, Susan Kegeles, James A McIntyre
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4234301?pdf=render
id doaj-025af986fedf40e0aacad80fc26d3917
record_format Article
spelling doaj-025af986fedf40e0aacad80fc26d39172020-11-25T00:07:16ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-01911e11106310.1371/journal.pone.0111063The Mpumalanga Men's Study (MPMS): results of a baseline biological and behavioral HIV surveillance survey in two MSM communities in South Africa.Tim LaneThomas OsmandAlexander MarrStarley B ShadeKristin DunkleTheodorus SandfortHelen StruthersSusan KegelesJames A McIntyreThe Mpumalanga Men's Study (MPMS) is the assessment of the Project Boithato HIV prevention intervention for South African MSM. Boithato aims to increase consistent condom use, regular testing for HIV-negative MSM, and linkage to care for HIV-positive MSM. The MPMS baseline examined HIV prevalence and associated risk behaviors, and testing, care, and treatment behaviors among MSM in Gert Sibande and Ehlanzeni districts in Mpumalanga province, South Africa in order to effectively target intervention activities. We recruited 307 MSM in Gert Sibande and 298 in Ehlanzeni through respondent-driven sampling (RDS) between September 2012-March 2013. RDS-adjusted HIV prevalence estimates are 28.3% (95% CI 21.1%-35.3%) in Gert Sibande, and 13.7% (95% CI 9.1%-19.6%) in Ehlanzeni. Prevalence is significantly higher among MSM over age 25 [57.8% (95% CI 43.1%-72.9%) vs. 17.9% (95% CI 10.6%-23.9%), P<0.001 in Gert Sibande; 34.5% (95%CI 20.5%-56.0%) vs. 9.1% (95% CI 4.6%-13.9%), P<0.001 in Ehlanzeni]. In Gert Sibande, prevalence is higher among self-identified gay and transgender MSM vs. other MSM [39.3% (95%CI, 28.3%-47.9%), P<0.01], inconsistent condom users [38.1% (18.1%-64.2%), P<0.05], those with a current regular male partner [35.0% (27.1%-46.4%), P<0.05], and those with lifetime experience of intimate partner violence with men [40.4%, (95%CI 28.9%-50.9%), P<0.05]. Prevalence of previous HIV testing was 65.8% (95%CI 58.8%-74.0%) in Gert Sibande, and 69.3% (95%CI 61.9%-76.8%) in Ehlanzeni. Regular HIV testing was uncommon [(34.6%, (95%CI 27.9%-41.4%) in Gert Sibande; 31.0% (95%CI 24.9%-37.8%) in Ehlanzeni]. Among HIV-positive participants, few knew their status (28.1% in Gert Sibande and 14.5% in Ehlanzeni), or were appropriately linked to care (18.2% and 11.3%, respectively), or taking antiretroviral therapy (13.6% and 9.6% respectively). MPMS results demonstrate the importance of implementing interventions for MSM to increase consistent condom use, regular HIV testing, and linkage and engagement in care for HIV-infected MSM.http://europepmc.org/articles/PMC4234301?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Tim Lane
Thomas Osmand
Alexander Marr
Starley B Shade
Kristin Dunkle
Theodorus Sandfort
Helen Struthers
Susan Kegeles
James A McIntyre
spellingShingle Tim Lane
Thomas Osmand
Alexander Marr
Starley B Shade
Kristin Dunkle
Theodorus Sandfort
Helen Struthers
Susan Kegeles
James A McIntyre
The Mpumalanga Men's Study (MPMS): results of a baseline biological and behavioral HIV surveillance survey in two MSM communities in South Africa.
PLoS ONE
author_facet Tim Lane
Thomas Osmand
Alexander Marr
Starley B Shade
Kristin Dunkle
Theodorus Sandfort
Helen Struthers
Susan Kegeles
James A McIntyre
author_sort Tim Lane
title The Mpumalanga Men's Study (MPMS): results of a baseline biological and behavioral HIV surveillance survey in two MSM communities in South Africa.
title_short The Mpumalanga Men's Study (MPMS): results of a baseline biological and behavioral HIV surveillance survey in two MSM communities in South Africa.
title_full The Mpumalanga Men's Study (MPMS): results of a baseline biological and behavioral HIV surveillance survey in two MSM communities in South Africa.
title_fullStr The Mpumalanga Men's Study (MPMS): results of a baseline biological and behavioral HIV surveillance survey in two MSM communities in South Africa.
title_full_unstemmed The Mpumalanga Men's Study (MPMS): results of a baseline biological and behavioral HIV surveillance survey in two MSM communities in South Africa.
title_sort mpumalanga men's study (mpms): results of a baseline biological and behavioral hiv surveillance survey in two msm communities in south africa.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2014-01-01
description The Mpumalanga Men's Study (MPMS) is the assessment of the Project Boithato HIV prevention intervention for South African MSM. Boithato aims to increase consistent condom use, regular testing for HIV-negative MSM, and linkage to care for HIV-positive MSM. The MPMS baseline examined HIV prevalence and associated risk behaviors, and testing, care, and treatment behaviors among MSM in Gert Sibande and Ehlanzeni districts in Mpumalanga province, South Africa in order to effectively target intervention activities. We recruited 307 MSM in Gert Sibande and 298 in Ehlanzeni through respondent-driven sampling (RDS) between September 2012-March 2013. RDS-adjusted HIV prevalence estimates are 28.3% (95% CI 21.1%-35.3%) in Gert Sibande, and 13.7% (95% CI 9.1%-19.6%) in Ehlanzeni. Prevalence is significantly higher among MSM over age 25 [57.8% (95% CI 43.1%-72.9%) vs. 17.9% (95% CI 10.6%-23.9%), P<0.001 in Gert Sibande; 34.5% (95%CI 20.5%-56.0%) vs. 9.1% (95% CI 4.6%-13.9%), P<0.001 in Ehlanzeni]. In Gert Sibande, prevalence is higher among self-identified gay and transgender MSM vs. other MSM [39.3% (95%CI, 28.3%-47.9%), P<0.01], inconsistent condom users [38.1% (18.1%-64.2%), P<0.05], those with a current regular male partner [35.0% (27.1%-46.4%), P<0.05], and those with lifetime experience of intimate partner violence with men [40.4%, (95%CI 28.9%-50.9%), P<0.05]. Prevalence of previous HIV testing was 65.8% (95%CI 58.8%-74.0%) in Gert Sibande, and 69.3% (95%CI 61.9%-76.8%) in Ehlanzeni. Regular HIV testing was uncommon [(34.6%, (95%CI 27.9%-41.4%) in Gert Sibande; 31.0% (95%CI 24.9%-37.8%) in Ehlanzeni]. Among HIV-positive participants, few knew their status (28.1% in Gert Sibande and 14.5% in Ehlanzeni), or were appropriately linked to care (18.2% and 11.3%, respectively), or taking antiretroviral therapy (13.6% and 9.6% respectively). MPMS results demonstrate the importance of implementing interventions for MSM to increase consistent condom use, regular HIV testing, and linkage and engagement in care for HIV-infected MSM.
url http://europepmc.org/articles/PMC4234301?pdf=render
work_keys_str_mv AT timlane thempumalangamensstudympmsresultsofabaselinebiologicalandbehavioralhivsurveillancesurveyintwomsmcommunitiesinsouthafrica
AT thomasosmand thempumalangamensstudympmsresultsofabaselinebiologicalandbehavioralhivsurveillancesurveyintwomsmcommunitiesinsouthafrica
AT alexandermarr thempumalangamensstudympmsresultsofabaselinebiologicalandbehavioralhivsurveillancesurveyintwomsmcommunitiesinsouthafrica
AT starleybshade thempumalangamensstudympmsresultsofabaselinebiologicalandbehavioralhivsurveillancesurveyintwomsmcommunitiesinsouthafrica
AT kristindunkle thempumalangamensstudympmsresultsofabaselinebiologicalandbehavioralhivsurveillancesurveyintwomsmcommunitiesinsouthafrica
AT theodorussandfort thempumalangamensstudympmsresultsofabaselinebiologicalandbehavioralhivsurveillancesurveyintwomsmcommunitiesinsouthafrica
AT helenstruthers thempumalangamensstudympmsresultsofabaselinebiologicalandbehavioralhivsurveillancesurveyintwomsmcommunitiesinsouthafrica
AT susankegeles thempumalangamensstudympmsresultsofabaselinebiologicalandbehavioralhivsurveillancesurveyintwomsmcommunitiesinsouthafrica
AT jamesamcintyre thempumalangamensstudympmsresultsofabaselinebiologicalandbehavioralhivsurveillancesurveyintwomsmcommunitiesinsouthafrica
AT timlane mpumalangamensstudympmsresultsofabaselinebiologicalandbehavioralhivsurveillancesurveyintwomsmcommunitiesinsouthafrica
AT thomasosmand mpumalangamensstudympmsresultsofabaselinebiologicalandbehavioralhivsurveillancesurveyintwomsmcommunitiesinsouthafrica
AT alexandermarr mpumalangamensstudympmsresultsofabaselinebiologicalandbehavioralhivsurveillancesurveyintwomsmcommunitiesinsouthafrica
AT starleybshade mpumalangamensstudympmsresultsofabaselinebiologicalandbehavioralhivsurveillancesurveyintwomsmcommunitiesinsouthafrica
AT kristindunkle mpumalangamensstudympmsresultsofabaselinebiologicalandbehavioralhivsurveillancesurveyintwomsmcommunitiesinsouthafrica
AT theodorussandfort mpumalangamensstudympmsresultsofabaselinebiologicalandbehavioralhivsurveillancesurveyintwomsmcommunitiesinsouthafrica
AT helenstruthers mpumalangamensstudympmsresultsofabaselinebiologicalandbehavioralhivsurveillancesurveyintwomsmcommunitiesinsouthafrica
AT susankegeles mpumalangamensstudympmsresultsofabaselinebiologicalandbehavioralhivsurveillancesurveyintwomsmcommunitiesinsouthafrica
AT jamesamcintyre mpumalangamensstudympmsresultsofabaselinebiologicalandbehavioralhivsurveillancesurveyintwomsmcommunitiesinsouthafrica
_version_ 1725419104494419968